Mr. Saketh Reddy serves as a Director of Chemeca Drugs Pvt Ltd. In addition to this role, Mr. Reddy serves as the Chief Commercial Officer of ScieGen Pharmaceuticals and Bactolac Pharmaceutical, overseeing corporate strategy and business development. He brings with him a multitude of knowledge of the pharmaceutical and nutraceutical industries.
Mr. Reddy joined Chemeca’ s leadership team in 2021 and oversees the commercial activities of the company.
He holds a Bachelor of Science in Business from Texas A&M University and a Master of Business Administration from Johns Hopkins University.Mr. Reddy brings over two decades of experience in the pharmaceutical industry in the areas of analytical research and development, pre-formulations, new product development and regulatory submissions. Before joining ScieGen, Mr. Reddy served as Associate Vice President with Aurobindo Pharma Limited in India, overseeing the research center in handling all kinds of sterile formulations. He has significant experience in Solid Oral dosages, liquids and Parenterals. Mr. Reddy has also spent over 12 years with Dr. Reddy’s Laboratories Limited as the Associate Director of New Product Development in their Generic Pharmaceutical division. Mr. Reddy is responsible for almost 100 ANDA, NDA, EU drug filings throughout the USA, Canada and Europe, and has several patents (US and WO). He has also written several publications prior to joining ScieGen. Mr. Reddy holds an MS degree in Pharmacy from Dr MGR Medical University in India.
Dr. Raghu Ram Pannala heads the Quality Assurance, Quality Control & Regulatory Affairs teams at Chemeca Drugs PVT Limited. He has over 27 years of experience in the Pharmaceutical industry, in the areas of Analytical Development, Quality Control, Quality Assurance, Regulatory Affairs, Compliance and Pharmacovigilance.
Dr. Raghu Ram Pannala has published 24 research publications during his career. He is a member of IPC [Indian Pharmacopeial Commission] and USP [United States Pharmacopeia] 2005-2010 monographs acquisition committee. He is a contributing author for PDA FDA Technical report – 80 , ‘Data Integrity Management System for Pharmaceutical Laboratories and sub team lead in the PDA Remote Audits & Inspections Team, and PDA COVID-19 PtC Task Force.
Dr. Pannala holds a Ph.D in Analytical Chemistry from Sri Krishnadevaraya University in India. He holds certifications such as a CQA [Certified Quality Auditor] and CMQ/OE [Certified manager for Organizational Excellence] from ASQ [American Society for Quality], Statistical Quality Control diploma from Indian Statistical institute.
Mr.Sambasivarao heads the overall site operations at Chemeca Drugs Pvt Ltd. He is a keen student from initial days excelled as chemical Engineer in Process Operations from BITS and University 2nd rank during post-graduation in Pharmaceutical Chemistry from Gulbarga University.
He has over 27 years of rich experience in API, HPAI, Peptides and Agro Technical fields having worked as a General Manager in Dr Reddys, Aurobindo and Nagarjuna Agro chemical industries.
He has excelled in Scale up, Validations, Operational excellence, facility creation in green field and brown field projects. Also has proven himself in QRA, HAZOP, PSM and instrumental in securing certifications and successfully completed USFDA and EUGMP audits
He has been well recognized by industry with awards like PSAI excellence award, Best operation group award and Best Train the trainer award etc.